TCTR20211106001
Not yet recruiting
Phase 3
Effect of nitrous oxide and oxygen mixture inhalation on rigid cystoscopy for pain management : A Double-blinded Randomized Controlled Trial.
/A0 sites54 target enrollmentNovember 6, 2021
ConditionsInclusion Criteria1.Patient who was performed by use rigid cystoscopy size 22 Fr2.Patient who was performed by use rigid cystoscopy size 22 Fr with tissue biopsy at bladder mucosa3.Patient who was performed by use rigid cystoscopy size 22 Fr with ureteral insertion size 6 Fr4.Femal and male patients age above 18 Yrs oldCystoscopyEntonoxPain
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Inclusion Criteria1.Patient who was performed by use rigid cystoscopy size 22 Fr2.Patient who was performed by use rigid cystoscopy size 22 Fr with tissue biopsy at bladder mucosa3.Patient who was performed by use rigid cystoscopy size 22 Fr with ureteral insertion size 6 Fr4.Femal and male patients age above 18 Yrs old
- Sponsor
- /A
- Enrollment
- 54
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Patient who was performed with Rigid Cystoscopy for diagnosis (22 Fr Size)
- •2\.Patient who was performed with Rigid Cystoscopy and bladder biopsy for diagnosis (22 Fr Size)
- •3\.Patient who was performed with Rigid Cystoscopy and ureteral stent insertion (22 Fr for Rigid Cystoscopy and 6 Fr for ureteral stent)
Exclusion Criteria
- •1\.patient who refuse this project
- •2\.History of lidocaine or nitrous mixture halation allergy
- •3\.patient with impairing pain perception
- •4\.patient with maxillofacial injury
- •5\.patient with pneumothorax
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
The Effects of Nitric Oxide for Inhalation on the Development of Chronic Lung Disease in Pre-term Infants.EUCTR2004-002312-29-DEINO Therapeutics800
Active, not recruiting
Phase 1
The Effects of Nitric Oxide for Inhalation on the development of chronic lung disease in pre-term infants. - INOT-27Prevention of chronic lung disease in pre-term infants ( gestational age < 29 weeks) with respiratory distress.MedDRA version: 7.0 Level: LLT Classification code 10054933EUCTR2004-002312-29-GBINO Therapeutics800
Active, not recruiting
Phase 1
The Effects of Nitric Oxide for Inhalation on the development of chronic lung disease in pre-term infants. - INOT-27Prevention of chronic lung disease in pre-term infants ( gestational age < 29 weeks) with respiratory distress.MedDRA version: 7.0Level: LLTClassification code 10054933EUCTR2004-002312-29-FIINO Therapeutics800
Active, not recruiting
Not Applicable
The Effects of Nitric Oxide for Inhalation on the development of chronic lung disease in pre-term infants. - INOT-27EUCTR2004-002312-29-ESINO Therapeutics600
Active, not recruiting
Not Applicable
The Effects of Nitric Oxide for Inhalation on the Development of Chronic Lung Disease in Pre-term InfantsPrevention of chronic lung disease in pre-term infants gestational age 29 weeks with respiratory distress.MedDRA version: 9.1Level: LLTClassification code 10028974Term: Neonatal respiratory distress syndromeEUCTR2004-002312-29-ITINO THERAPEUTICS